Results 301 to 310 of about 110,424 (352)
Some of the next articles are maybe not open access.
Linaclotide (Linzess) for Functional Constipation
The Medical Letter on Drugs and Therapeutics, 2023The guanylate cyclase-C receptor agonist linaclotide (Linzess – Abbvie/Ironwood) was first approved by the FDA in 2012 for treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation in adults.
openaire +2 more sources
Age of Onset of Functional Constipation
Journal of Pediatric Gastroenterology and Nutrition, 2016ABSTRACTIn a review of 538 children with functional constipation, we analyzed ages of presentation and onset, symptom duration, and behavioral/developmental problems. We divided the subjects into quartiles (Q1–Q4) based on age of onset. Median onset age was 2.3 years. The oldest group had the shortest symptom duration before referral at 1.8 ± 1.8 years
Stanton, Malowitz +4 more
openaire +2 more sources
Management of functional constipation in childhood
British Journal of Community Nursing, 2003Functional constipation is a common childhood condition. In the majority of cases the constipation develops as a result of a complex weave of factors including specific triggers, e.g. reduced fluid intake following a viral infection or periods of restricted access to the toilet.
openaire +2 more sources
FUNCTIONAL CONSTIPATION IN CHILDREN
Journal of Urology, 2004ABSTRACT Purpose: Constipation in children increases the likelihood of urinary incontinence, bladder overactivity, dyscoordinated voiding, a large capacity, poorly emptying bladder, recurrent urinary tract infection and deterioration of vesicoureteral reflux.
J.W. CHASE +4 more
openaire +1 more source
Functional Constipation and Obstructed Defecation
Surgical Clinics of North AmericaConstipation encompasses symptoms of decreased colonic motility or difficulty with the defecation process. As a broad definition, this can be inclusive of functional constipation (FC) or colonic inertia, obstructed defecation (OD), and irritable bowel syndrome-constipation type (IBS-CS). After excluding IBS-C, FC and OD diagnosis and management require
Mary T, O'Donnell, Sarah M, Haviland
openaire +2 more sources
Oral Prucalopride in Children With Functional Constipation
Journal of Pediatric Gastroenterology and Nutrition, 2013ABSTRACTBackground and Objectives:Prucalopride is a selective, high‐affinity 5‐HT4 receptor agonist with gastrointestinal prokinetic activities. The aim of this study was to evaluate the pharmacokinetics, efficacy, safety, and tolerability of prucalopride oral solution in children, ages 4 years or older to 12 years or younger, with functional ...
Winter, Harland S. +8 more
openaire +2 more sources
Functional Constipation and Cow's‐Milk Allergy
Journal of Pediatric Gastroenterology and Nutrition, 2014N ...
Miceli Sopo S., Arena R., Scala G.
openaire +2 more sources
Seminars in pediatric surgery, 1995
Constipation is a common problem in children. Most patients have functional constipation, with or without soiling. The treatment program for functional constipation includes various forms of behavioral therapy and psychological approaches, and consists of education, disimpaction, prevention of reaccumulation of stools with fiber and laxatives, and ...
openaire +1 more source
Constipation is a common problem in children. Most patients have functional constipation, with or without soiling. The treatment program for functional constipation includes various forms of behavioral therapy and psychological approaches, and consists of education, disimpaction, prevention of reaccumulation of stools with fiber and laxatives, and ...
openaire +1 more source
Functional constipation in childhood
Nurse Prescribing, 2011Although idiopathic constipation is one of the commonest problems in childhood, it is often the most poorly managed.Left untreated, constipation can become chronic and result in devastating problems, including soiling, as well as pain and distress for the child and family.
openaire +1 more source
American Journal of Gastroenterology, 2014
IBS with constipation (IBS-C) and chronic constipation (CC) can be difficult to distinguish clinically. The Rome III criteria create mutual exclusion between IBS-C and CC, based on the presence of abdominal pain, which is a defining criterion for IBS-C. Previous surveys found that up to 45% of CC patients have abdominal pain and other IBS features.
Filippo, Cremonini, Anthony, Lembo
openaire +2 more sources
IBS with constipation (IBS-C) and chronic constipation (CC) can be difficult to distinguish clinically. The Rome III criteria create mutual exclusion between IBS-C and CC, based on the presence of abdominal pain, which is a defining criterion for IBS-C. Previous surveys found that up to 45% of CC patients have abdominal pain and other IBS features.
Filippo, Cremonini, Anthony, Lembo
openaire +2 more sources

